Skip to content
Home/Companies/Pharma/Fertin Pharma

Fertin Pharma

Pharma·Denmark·Exited 2021·Held 4yr
Entry
2017
Hold
4yr
Exit
2021

Who owns Fertin Pharma?

Fertin Pharma was owned by EQT through EQT Mid Market Europe (2016 vintage) from 2017 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-18

EQT
Investor
EQT
EQT Mid Market Europe · 2016 · Buyout

Key facts

HQDenmark
SectorPharma
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from EQT Mid Market Europe

Other portfolio companies in the same fund.

Oterra
Active
FoodTechDenmark· 2021
Magnific (formerly Freepik)
Active
SoftwareSpain· 2020
Recover Nordic
Active
Business ServicesNorway· 2020
Ellab
Exited 2023
HealthTechDenmark· 2019
to
BBS Automation
Exited 2024
IndustrialsGermany· 2018
to
Dunlop
Exited 2024
IndustrialsNetherlands· 2018
to

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Advantice Health
Advantice Health
Active
TA AssociatesUS
Alvogen
Alvogen
Active
CVC Capital Partners
CANbridge
CANbridge
Active
General AtlanticChina
Ceva
Ceva
Exited 2025
iXO Private EquityFrance
to
curia
curia
Active
The Carlyle GroupUS
Ideal Cures Pvt. Ltd.
Ideal Cures Pvt. Ltd.
Active
TA AssociatesIndia
Track Fertin Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Fertin Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Fertin Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue